APPLICATION
ANDA078491
TYPE
ANDA
ORIGINAL APPROVAL
2008-09-25
LATEST ACTION
2019-12-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ALPRAZOLAMDiscontinued
ALPRAZOLAM 1MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.25MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 2MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.5MG · TABLET · ORAL
Approval history
2019-12-31Labeling · Supplement 13 · standardAP
2011-11-29Labeling · Supplement 5AP
2008-12-12Labeling · Supplement 1AP
2008-09-25OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.